Dissolution Performance Testing Of Transdermal Systems
نویسندگان
چکیده
منابع مشابه
Novel transdermal drug delivery systems
Background and aim: Eczema is a common inflammatory skin disease. Although history and physical examination are important in diagnosis of allergen, because of extent of environmental allergens, those are not simply recognized. The objective of this study was to determine allergens in patients with contact or atopic dermatitis referred to Razi hospital.Materials and Meth...
متن کاملDissolution Testing of
h o l l e n be c k @ u p m i n c. co m Raafat Fahmy1, William Marnane1 and Dennis Bensley, Jr.1 , R. Gary Hollenbeck*2 1Division of Manufacturing Technologies, Office of New Animal Drug Evaluation, Center for Veterinary Medicine, Food and Drug Administration, Rockville, MD 2Associate Professor, Department of Pharmaceutical Sciences, University of Maryland School of Pharmac y and Vice President,...
متن کاملDissolution testing of orally disintegrating tablets.
For industrially manufactured pharmaceutical dosage forms, product quality tests and performance tests are required to ascertain the quality of the final product. Current compendial requirements specify a disintegration and/or a dissolution test to check the quality of oral solid dosage forms. These requirements led to a number of compendial monographs for individual products and, at times, the...
متن کاملIntersection-union Tests in Dissolution Proole Testing
For k = 1; : : : ; p, let t k denote the time points at which dissolution prooles are collected , and let X ik and Y jk represent the proportion of drug dissolved from dosage unit i for the reference drug and for dosage unit j for the test drug respectively, We assume that the samples are drawn from independent multivariate p normal populations with mean vectors X and Y respectively and the sam...
متن کاملThree - Stage Statistical Dissolution Testing Procedures
I. Introduction The US Food and Drug Administration sets performance limit on dissolution in terms of a specific percentage Q that the drug product is required to be dissolved at a specified time. Based on inferences from correlated bioavailability studies, these dissolution specifications were intended to assure that at least 80% of the labeled quantity of drug was available. When carried out ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Dissolution Technologies
سال: 1995
ISSN: 1521-298X
DOI: 10.14227/dt020195p7